Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

EPiC-VFG

Financiado

The mystery of differentiation: exploring the link between enhancer priming and...

The mystery of differentiation: exploring the link between enhancer priming and cell cycle in ventral foregut stem cells Pluripotent stem cell differentiation to disease targeted cell types has historically produced poor or inconsistent outcomes. The Brickman lab recently suggested that pausing differentiation, allowing cells to grow, and catch up a... ver más

14/03/2027

UCPH

215K€

Presupuesto del proyecto: 215K€

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-22

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023

I+D

Cerrada hace 1 año

0% 100% 100%

1 Participantes

UCPH

214.93K€ | Lider

Proyectos interesantes

BFU2008-02299 LA CASCADA TRANSCRIPCIONAL INDUCIDA POR NEUROGENINA 3 EN EL... 121K€ Cerrado

BFU2014-55275-P ANALISIS FUNCIONAL DE LOS MECANISMOS EPIGENETICOS DE REPROGR... 157K€ Cerrado

SAF2017-86242-R REDES DE REGULACION GENICA EN ISLOTES PANCREATICOS E INSULIN... 182K€ Cerrado

MetEpiStem Dissecting the crosstalk between metabolism and transcriptio... 1M€ Cerrado

PID2019-109354GB-I00 EL PAPEL DEL C/EBPA EN LA REMODELACION DEL GENOMA DURANTE LA... 472K€ Cerrado

SAF2013-44866-R CELULAS ES HAPLOIDES PARA INVESTIGACION EN CANCER 218K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 34 meses Fecha Inicio: 2024-04-22
Fecha Fin: 2027-03-14

Líder del proyecto

KOBENHAVNS UNIVERSITET

TRL 4-5

Presupuesto del proyecto 215K€

Descripción del proyecto Pluripotent stem cell differentiation to disease targeted cell types has historically produced poor or inconsistent outcomes. The Brickman lab recently suggested that pausing differentiation, allowing cells to grow, and catch up at the level of the enhancer network, leads to improved differentiation. In particular, the Brickman lab has demonstrated that expansion of endoderm at the ventral foregut stage (VFG) increases the efficiency and efficacy of pancreatic endocrine differentiation. The mechanism by which this occurs is unknown, but it involves the re-equilibration of enhancer networks and rearrangements in the cell cycle. I hypothesise that these two processes are tightly connected and to address cause and effects and understand the nature of this link, I will focus on how FOXA1, a factor required for expansion-specific pancreatic enhancer reorganization, acts to couple growth to genome rearrangement, how it interacts with the REST/CoREST/KBTBD4 complex to facilitate enhancer commissioning/decommissioning and finally whether proliferation-induced alterations to specific cell cycles phases drive this enhancer reconfiguration. The results of this project will significantly impact on regenerative medicine research as they will help formulating a differentiation protocol that produces in a more efficient way pancreatic endoderm and pancreatic endocrine cells. Although this fellowship exploits pancreatic differentiation as a model, its implications are broad, as a role of proliferation in preparing appropriate transcriptional responses for differentiating cells would represent a new paradigm for the link between growth and lineage specification.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores